PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsMedicure
Medicure(MCU)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Annual sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
AggrastatTirofiban1998-05-14
Myocardial infarction
,
Coronary disease
,
Unstable angina
ZypitamagPitavastatin2017-07-142024-2031
Hypercholesterolemia
,
Hypertriglyceridemia
,
Hyperlipoproteinemias
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Tirofiban
renal insufficiency
,
hemorrhage
,
subarachnoid hemorrhage
,
covid-19
,
coronavirus infections
,
respiratory insufficiency
,
embolism and thrombosis
,
pneumonia
,
viral pneumonia
,
stable angina
,
death
,
cerebral infarction
,
syndrome
,
unstable angina
,
thromboembolism
,
endovascular procedures
,
ischemic stroke
,
myocardial infarction
,
st elevation myocardial infarction
,
infarction
,
coronary artery disease
,
acute coronary syndrome
,
stroke
,
inferior wall myocardial infarction
,
percutaneous coronary intervention
,
thrombosis
,
no-reflow phenomenon
,
non-st elevated myocardial infarction
,
coronary disease
,
intracranial aneurysm
,
aneurysm
,
balloon angioplasty coronary
,
diabetes mellitus
,
thrombolytic therapy
,
thrombectomy
,
myocardial ischemia
,
magnetic resonance imaging
,
disease
,
pathologic dilatation
,
ischemia
,
pathologic constriction
Bevifimod
healthy volunteers/patients
,
gastrointestinal neoplasms
,
follicular lymphoma
,
carcinoma
,
pancreatic neoplasms
,
neoplasm metastasis
,
respiratory tract diseases
,
pleural effusion
,
lung diseases
,
respiratory tract neoplasms
,
bronchogenic carcinoma
,
thoracic neoplasms
,
neoplasms by site
,
malignant pleural effusion
,
pleural diseases
,
pleural neoplasms
,
myeloid leukemia acute
,
neoplasms
,
squamous cell carcinoma of head and neck
,
head and neck neoplasms
,
recurrence
,
squamous cell carcinoma
,
squamous cell neoplasms
,
multiple myeloma
,
chronic hepatitis c
,
abdominal pain
,
asthma
,
adenocarcinoma of lung
,
non-small-cell lung carcinoma
,
type 2 diabetes mellitus
,
psoriasis
,
colorectal neoplasms
,
diabetes mellitus
,
lung neoplasms
,
non-hodgkin lymphoma
,
adenocarcinoma
,
breast neoplasms
,
crohn disease
,
stroke
,
ischemic stroke
,
pulmonary embolism
,
skin diseases
,
papulosquamous skin diseases
,
essential hypertension
,
restless legs syndrome
,
hyperglycemia
,
rheumatoid arthritis
,
respiratory distress syndrome
,
vascular access devices
,
catheter obstruction
,
heart arrest
,
ischemia
,
type 1 diabetes mellitus
,
embolism
,
polycystic kidney diseases
,
hypertension
,
myocardial infarction
,
infarction
,
hiv infections
,
kidney diseases
,
diabetic neuropathies
,
diabetic nephropathies
,
fibrosis
,
idiopathic pulmonary fibrosis
,
pulmonary fibrosis
,
liver cirrhosis
,
parkinson disease
,
peripheral arterial disease
,
intermittent claudication
,
peripheral vascular diseases
,
pneumonia
,
disease progression
,
hypersensitivity
,
extrinsic allergic alveolitis
Retinol
crohn disease
,
ulcerative colitis
,
chronic pancreatitis
,
exocrine pancreatic insufficiency
,
spondylarthropathies
,
spondylarthritis
,
spondylitis
Pyridoxal
tuberculosis
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use